Corgentech to Present at Pacific Growth Equities Life Sciences Growth Conference and Needham & Company Fifth Annual Biotechnolo
June 07 2006 - 8:00AM
PR Newswire (US)
SOUTH SAN FRANCISCO, Calif., June 7 /PRNewswire-FirstCall/ --
Corgentech Inc. (NASDAQ:CGTK) today announced that John P.
McLaughlin, the company's chief executive officer, will present at
the Pacific Growth Equities Life Sciences Growth Conference on
Monday, June 12, 2006 at 8:30 a.m. PDT in San Francisco; and at the
Needham & Company Biotechnology and Medical Technology
Conference on Wednesday, June 14, 2006 at 9:00 a.m. EDT in New York
City. To access the live webcasts or the subsequent archived
recordings, log on to http://www.corgentech.com/ and go to the
Investors page, and click on Webcasts. Please connect to
Corgentech's website several minutes prior to the start of the
webcast to ensure adequate time for any software download that may
be necessary. About Corgentech Corgentech is a late-stage
biopharmaceutical company that seeks to be the leader in the
development and commercialization of novel therapeutic treatments
for pain. The company has four drug candidates in clinical
development for multiple potential indications, the most advanced
of which, 3268, has completed Phase 3 clinical trials. To reflect
the company's core focus on novel pain management therapies, the
board of directors recently voted to change the company name to
Anesiva. If approved by stockholders at the annual meeting on June
21, 2006, the name change will become effective immediately
thereafter. Corgentech is based in South San Francisco, CA.
DATASOURCE: Corgentech Inc. CONTACT: Jennifer Cook Williams, Vice
President, Investor Relations of Corgentech Inc., +1-650-624-9600,
or Web site: http://www.corgentech.com/
Copyright
Corgentech (NASDAQ:CGTK)
Historical Stock Chart
From Apr 2024 to May 2024
Corgentech (NASDAQ:CGTK)
Historical Stock Chart
From May 2023 to May 2024